China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20 at 01:00 AM513060+0.38%159859+1.32%
MoneyMasters Podcast: Where to Invest NOW in AI, Biotech, Small Caps, & Gold!Barchart Option·Jul 16 at 10:58 AMGLL+3.08%159859+1.32%
China's 1H25 Innovative Drug Out-Licensing Deal Value Rises to USD110 Billion, Hitting Fresh Record HighAASTOCKS News·Jul 13 at 04:25 AM159837+1.04%159859+1.32%
China's Outbound Licensing of Innovative Drugs in First Half Nears Last Year's TotalYicai·Jul 13 at 02:28 AM159859+1.32%513700+0.35%
Guotai Asset Management flags China pharma re-rating as 2026 essential drugs list adds 165 medicinesPUBT·Jul 10 at 04:25 AM520690-0.28%520880-0.46%
HSI Company: Hang Seng Biotech Index Rebounds 17%+ from Jun Trough as Constituents Step Up Share BuybacksAASTOCKS News·Jul 9 at 09:35 PM0HSCI159102+0.40%
China’s biotech boom: RAS-targeted drugs challenge US dominanceSCMP·Jul 8 at 03:05 AM01276-0.52%600276-1.04%
SH Comp Gains 3 Pts at Half-Day; HUA HONG GRACE Surges Over 11%, Innovative Drug Concept Stocks RallyAASTOCKS News·Jul 5 at 11:05 PM399001+2.21%06969-2.23%
Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™Unusual Whales·Jul 3 at 09:32 AMARKG-1.82%159102+0.40%
China’s biotech boom: record 5,215 clinical drug trials reported in 2025SCMP·Jun 23 at 07:02 PM159615+0.59%159992+1.57%
China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025Yicai·Jun 23 at 04:22 AM513060+0.38%159837+1.04%
<![CDATA[New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge]]>Pharmexec·Jun 3 at 11:07 AM159849+0.61%510660+0.86%
BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growthBambooWorks·Jun 1 at 01:05 AM02269+2.49%WXXWY+1.65%
Brief: WuXi Biologics signed 69 new projects in the first four months, maintaining a target of up to 17% revenue growth for the yearBambooWorks·Jun 1 at 12:21 AM02269+2.49%WXXWY+1.65%
